Standard BioTools Inc. Current Assets
Standard BioTools Inc. (LAB) had Current Assets of $516.87 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $516.87M.
- 2026-03-31: Assets, Current $521.45M.
- 2025-12-31: Assets, Current $454.26M.
- 2025-09-30: Assets, Current $472.44M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $516.87M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $521.45M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $454.26M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $472.44M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $506.04M 10-Q · filed 2025-08-15 | |
| 2025-03-31 | $344.02M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $375.88M 10-K · filed 2026-03-16 | $375.88M 10-K · filed 2025-03-11 |
| 2024-09-30 | $453.61M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $480.03M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $547.57M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $158.22M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $170.74M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $183.07M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $194.93M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $208.81M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $229.02M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $250.88M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $73.20M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $72.07M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $73.47M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $78.21M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $96.33M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $117.66M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $122.66M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $78.45M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $82.43M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $96.10M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $96.55M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $106.78M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $111.48M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $127.11M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $71.86M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $75.25M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $81.00M 10-Q · filed 2018-05-08 | |
| 2018-01-01 | $94.95M 10-K · filed 2019-03-18 | |
| 2017-12-31 | $94.80M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $96.17M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $79.13M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $86.11M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $96.67M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $108.09M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $127.04M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $137.80M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $144.09M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $145.45M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $143.38M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $155.23M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $155.90M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $132.82M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $127.43M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $178.81M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $104.58M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $86.66M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $80.54M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $98.56M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $101.21M 10-K · filed 2014-03-12 | |
| 2012-09-30 | $105.54M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $55.70M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $56.66M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $70.03M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $76.03M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $80.99M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $20.88M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |